Reflect Scientific Inc RSCF

$0.06 0.00 (-3.17%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
PE ratio
—
Forward PE
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
35,000
Avg volume
104,490
Day's range
$0.05 – $0.06
Shares out
—
Stochastic %K
38%
Beta
—
Analysts
Strong Buy
Price target
—

Price

Company profile

Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purific...

Show more

Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products; and UV detectors and vial products. It serves hospitals, diagnostic laboratories, pharmaceutical and biotech companies, universities, governments, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. The company was founded in 1999 and is based in Orem, Utah.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
801 226 4100
Website
https://reflectscientific.com
Address
1266 South 1380 West, Orem, United States

Latest news

No headlines yet.